StockData
MiNK Therapeutics, Inc. logo

MiNK Therapeutics, Inc. (INKT) stock

INKTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$8.84−0.45 (-4.79%)

Close on Nov 18, 2026Market cap $45.11MP/E –Yield –

MiNK Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

MiNK Therapeutics's market cap was $52.11M on Nov 11, 2026, against $42.96M a year earlier. Over the last 5 years it ranged from $25.14M to $107.84M, with a median of $49.56M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$52.11M+14.3%
2025Dec 31, 2025$45.57M+79.3%
2024Dec 31, 2024$25.42M-30.5%
2023Dec 29, 2023$36.56M-57.7%
2022Dec 30, 2022$86.41M-19.9%
2021Dec 31, 2021$107.84M–

More MiNK Therapeutics figures

See a number that looks wrong?